178 related articles for article (PubMed ID: 31789304)
1. Farber disease: report of three cases with joint involvement mimicking juvenile idiopathic arthritis.
Moghadam SH; Tavasoli AR; Modaresi M; Ziaee V
J Musculoskelet Neuronal Interact; 2019 Dec; 19(4):521-525. PubMed ID: 31789304
[TBL] [Abstract][Full Text] [Related]
2. Farber disease in infancy resembling juvenile idiopathic arthritis: identification of two new mutations and a good early response to allogeneic haematopoietic stem cell transplantation.
Torcoletti M; Petaccia A; Pinto RM; Hladnik U; Locatelli F; Agostoni C; Corona F
Rheumatology (Oxford); 2014 Aug; 53(8):1533-4. PubMed ID: 24614645
[No Abstract] [Full Text] [Related]
3. Farber Disease Mimicking Juvenile Idiopathic Arthritis: The First Reported Case in Qatar and Review of the Literature.
Al-Naimi A; Toma H; Hamad SG; Ben Omran T
Case Rep Genet; 2022; 2022():2555235. PubMed ID: 35186337
[TBL] [Abstract][Full Text] [Related]
4. Atypical presentation of infantile-onset farber disease with novel ASAH1 mutations.
Kim SY; Choi SA; Lee S; Lee JS; Hong CR; Lim BC; Kang HJ; Kim KJ; Park SH; Choi M; Chae JH
Am J Med Genet A; 2016 Nov; 170(11):3023-3027. PubMed ID: 27411168
[TBL] [Abstract][Full Text] [Related]
5. Farber lipogranulomatosis type 1--late presentation and early death in a Croatian boy with a novel homozygous ASAH1 mutation.
Cvitanovic-Sojat L; Gjergja Juraski R; Sabourdy F; Fensom AH; Fumic K; Paschke E; Levade T
Eur J Paediatr Neurol; 2011 Mar; 15(2):171-3. PubMed ID: 20609603
[TBL] [Abstract][Full Text] [Related]
6. Farber lipogranulomatosis with predominant joint involvement mimicking juvenile idiopathic arthritis.
Kostik MM; Chikova IA; Avramenko VV; Vasyakina LI; Le Trionnaire E; Chasnyk VG; Levade T
J Inherit Metab Dis; 2013 Nov; 36(6):1079-80. PubMed ID: 23385296
[TBL] [Abstract][Full Text] [Related]
7. A novel mutation in an atypical presentation of the rare infantile Farber disease.
Al Jasmi F
Brain Dev; 2012 Jun; 34(6):533-5. PubMed ID: 21982811
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of acid ceramidase deficiency in a neonatal form of Farber disease: identification of the first large deletion in ASAH1 gene.
Alves MQ; Le Trionnaire E; Ribeiro I; Carpentier S; Harzer K; Levade T; Ribeiro MG
Mol Genet Metab; 2013 Jul; 109(3):276-81. PubMed ID: 23707712
[TBL] [Abstract][Full Text] [Related]
9. Farber disease in a patient from China.
Bao X; Ma M; Zhang Z; Xu Y; Qiu Z
Am J Med Genet A; 2020 Sep; 182(9):2184-2186. PubMed ID: 32706452
[TBL] [Abstract][Full Text] [Related]
10. Novel biochemical abnormalities and genotype in Farber disease.
Muranjan M; Agarwal S; Lahiri K; Bashyam M
Indian Pediatr; 2012 Apr; 49(4):320-2. PubMed ID: 22565078
[TBL] [Abstract][Full Text] [Related]
11. [A case report of childhood Farber's disease and literature review].
Bao XH; Tian JM; Ji TY; Chang XZ
Zhonghua Er Ke Za Zhi; 2017 Jan; 55(1):54-58. PubMed ID: 28072961
[No Abstract] [Full Text] [Related]
12. Spinal muscular atrophy and Farber disease due to ASAH1 variants: A case report.
Lee BH; Mongiovi P; Levade T; Marston B; Mountain J; Ciafaloni E
Am J Med Genet A; 2020 Oct; 182(10):2369-2371. PubMed ID: 32627310
[TBL] [Abstract][Full Text] [Related]
13. Polyarticular Arthritis and Spinal Muscular Atrophy in Acid Ceramidase Deficiency.
Teoh HL; Solyom A; Schuchman EH; Mowat D; Roscioli T; Farrar M; Sampaio H
Pediatrics; 2016 Oct; 138(4):. PubMed ID: 27650050
[TBL] [Abstract][Full Text] [Related]
14. Disseminated lipogranulomatosis.
Mondal RK; Nandi M; Datta S; Hira M
Indian Pediatr; 2009 Feb; 46(2):175-7. PubMed ID: 19242039
[TBL] [Abstract][Full Text] [Related]
15. Molecular analyses of novel ASAH1 mutations causing Farber lipogranulomatosis: analyses of exonic splicing enhancer inactivating mutation.
Bashyam MD; Chaudhary AK; Kiran M; Reddy V; Nagarajaram HA; Dalal A; Bashyam L; Suri D; Gupta A; Gupta N; Kabra M; Puri RD; RamaDevi R; Kapoor S; Danda S
Clin Genet; 2014 Dec; 86(6):530-8. PubMed ID: 24355074
[TBL] [Abstract][Full Text] [Related]
16. Early morphological diagnosis of Farber disease.
Nivaggioni V; Cano A; Arnoux I; Michel G; Loosveld M
Br J Haematol; 2016 Oct; 175(2):189. PubMed ID: 27471081
[No Abstract] [Full Text] [Related]
17. Acid ceramidase deficiency associated with spinal muscular atrophy with progressive myoclonic epilepsy.
Gan JJ; Garcia V; Tian J; Tagliati M; Parisi JE; Chung JM; Lewis R; Baloh R; Levade T; Pierson TM
Neuromuscul Disord; 2015 Dec; 25(12):959-63. PubMed ID: 26526000
[TBL] [Abstract][Full Text] [Related]
18. C26-Ceramide as highly sensitive biomarker for the diagnosis of Farber Disease.
Cozma C; Iurașcu MI; Eichler S; Hovakimyan M; Brandau O; Zielke S; Böttcher T; Giese AK; Lukas J; Rolfs A
Sci Rep; 2017 Jul; 7(1):6149. PubMed ID: 28733637
[TBL] [Abstract][Full Text] [Related]
19. Optic Nerve Involvement in Farber Lipogranulomatosis: Expanding the Phenotypic Spectrum.
Alamri AS; Alshowaeir DA; AlFaiz AA; Al Mousawi FH; Mahmoud AA; Alhashim AH
J Neuroophthalmol; 2019 Sep; 39(3):391-393. PubMed ID: 31022067
[No Abstract] [Full Text] [Related]
20. ASAH1 pathogenic variants associated with acid ceramidase deficiency: Farber disease and spinal muscular atrophy with progressive myoclonic epilepsy.
Elsea SH; Solyom A; Martin K; Harmatz P; Mitchell J; Lampe C; Grant C; Selim L; Mungan NO; Guelbert N; Magnusson B; Sundberg E; Puri R; Kapoor S; Arslan N; DiRocco M; Zaki M; Ozen S; Mahmoud IG; Ehlert K; Hahn A; Gokcay G; Torcoletti M; Ferreira CR
Hum Mutat; 2020 Sep; 41(9):1469-1487. PubMed ID: 32449975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
